Connected clinical research operations.
Seven modules — study delivery, documentation, pharmacy, quality and delegation — working as one governed record, so nothing has to be reconciled by hand.
Why fragmented systems weaken research control?
Clinical research relies on coordinated work across study teams, investigators, quality managers, and pharmacy staff. The lack of a unified system pushes research teams to move between different research software to confirm progress, check documents, and track responsibilities. Unfortunately, it reduces operational clarity, weakens day-to-day control, and places additional pressure on teams responsible for maintaining compliant, inspection-ready research operations.
Separate systems hold different parts of the study record. Time shifts from study oversight to verifying which version is correct.
Each role sees one quarter of the study. Nobody holds the complete operational view at the moment they need it.
LOGGED
OPENED
UNASSIGNED
STALLED
Responsibility moves between teams without a single activity view. Delayed follow-up leaves issues unresolved.
Audit prep means rebuilding study history by hand. Gaps surface late — often once inspection is already booked.
Seven connected clinical research software modules in one AQ platform
AQ clinical research platform unifies the core capabilities required to manage regulated clinical research within one structured environment. Each capability supports a specific operational function across the study lifecycle while remaining connected through the same research platform. So your research teams never feel frustrated over managing and understanding trial data.
AQ connects the control points
that research teams manage together
Clinical research control depends on coordination across documentation, study operations, quality oversight, and pharmacy accountability. So, AQ ensures that all documentation, operational activity, quality actions, and pharmacy records are fully linked within the same research environment. It gives research teams end-to-end visibility across the entire study lifecycle, so it’s easier to understand study progress, resolve issues, and maintain inspection readiness.
Study Operations
Core CTMS capabilities help maintain visibility across study setup, participant activity, visit schedules, and operational milestones. Research teams track progress and responsibilities through one operational record.
Pharmacy Control
ePSF maintains pharmacy documentation, investigational product accountability, and drug management records within the same research environment as study documentation and operational activity.
Research Documentation
eISF and eTMF maintain structured study documentation with controlled filing, version history, and clear ownership. Research teams access complete investigator site and trial master records without searching across separate systems.
Quality, CAPA, and DOA
Deviation reviews, incident reports, corrective actions, and delegation records remain organised within one controlled quality process. Clear ownership, traceable actions, and structured delegation oversight support stronger governance across study operations.
Why research teams choose the AQ platform.
Built with one intention: to simplify, modernise and accelerate clinical research operations, while keeping the control regulated environments demand.
Research-informed design
Over 20 years of clinical research experience shaped the platform architecture — no margin for fragmented oversight.
Connected operational visibility
Each module operates independently while remaining connected through the same structure, for complete oversight.
Easy and practical adoption
An intuitive interface and guided onboarding help research teams adopt quickly and confidently.
Governed platform evolution
Continuous development aligned with GCP, UK GDPR, the Data Protection Act 2018 and MHRA expectations.
AQ platform implementation & interoperability
AQ supports phased adoption across NHS organisations, sponsors, CROs, academic research centres, and private research sites operating with mixed systems, manual processes, and different levels of digital maturity.
Which AQ modules fit your environment, and how setup is planned.
Study structures, documentation, users and access roles personalised.
Live sessions, guides and tutorials so teams learn at their own pace.
We stay involved past go-live until the platform feels routine.
Key questions beyond software features
Which AQ modules do organisations usually start with?
Most organisations begin with the module under the greatest pressure — the investigator site file (eISF), quality management (QMS) or CAPA — and introduce further modules as their workflows connect. For NHS R&D teams, we review obligations under MHRA, HRA and NIHR; for sponsors, CROs and academic units, the equivalent oversight requirements and existing systems. In each case we recommend the smallest combination of modules that resolves the immediate need — from CTMS, eTMF, eISF, ePSF, QMS, CAPA and Digital DoA — so no organisation adopts capability it will not use.
How does deployment and pricing work?
Organisations may deploy a single module or the full platform, and pay only for the capability they use. There is no enterprise contract and no organisation-wide rollout requirement: modules are introduced by priority and expanded as workflows connect. Pricing is modular and scaled to study volume, provided as a tailored quotation rather than a fixed list price. NHS Trusts procure through G-Cloud, using their established route; sponsors, CROs and academic groups adopt the same modular model, keeping cost proportionate to activity. AQ is designed to fit a research budget rather than an enterprise one.
Does AQ support a single site, and a CRDC or multi-site network?
Both. AQ provides a single site with consistent structure across concurrent studies, and places a multi-site network on one connected record — whether an NHS CRDC or hub-and-spoke arrangement, or a sponsor’s or CRO’s network of sites. Each site operates to the same standard, while the coordinating hub, sponsor or CRO retains visibility of recruitment, readiness and risk across every site. This network-wide evidence is precisely what sponsors request at feasibility.
How does AQ keep research inspection-ready?
AQ maintains inspection readiness as a continuous state rather than a pre-inspection exercise. Site files remain current, delegation remains attributable, and quality issues carry clear ownership and evidence — aligned to ICH-GCP E6(R3), MHRA inspection expectations and ALCOA+, and to 21 CFR Part 11 where FDA requirements apply. When MHRA, a sponsor or an internal audit makes a request, the record is already structured and retrievable.
Does AQ use AI, and is it safe for regulated research?
Yes. AQ includes governed AI, delivered as Connected Intelligence, which assists with routine data management: reading and filing documents, suggesting placeholders, and identifying outstanding items across the record. It is human-in-the-loop by design — AQ proposes, a named individual reviews and confirms, and every action is recorded in the audit trail. The AI never closes a record or applies a signature on anyone’s behalf, and it operates within the same controls as the wider platform: UK-hosted and aligned to NHS DSPT.
How is AQ different from EDGE, REDCap or a standalone eISF?
Each of those systems controls one part of the picture and leaves the connections to your staff. EDGE serves as the portfolio and KPI layer, whereas AQ is the operational record that produces the performance EDGE reports; the two operate alongside one another. REDCap captures study data but does not manage site documentation, delegation, pharmacy or quality. A standalone eISF, such as SiteVault, files site documents but does not connect them to recruitment, CAPA or investigational product accountability. AQ connects each of these on a single record, which is what enables teams to manage large portfolios over many years without re-platforming.
What distinguishes AQ from enterprise platforms?
Enterprise platforms such as Veeva control one part of the trial and require the organisation to integrate the remainder, at enterprise cost. AQ connects study operations, documentation, delegation, pharmacy and quality on a single record — modular, straightforward to adopt, UK-hosted, and without an enterprise contract. It supports NHS sites, academic units, sponsors and CROs, and is proven in NHS research, with six years of continuous daily use and more than 150 studies managed on one controlled record.
Trusted where research actually happens.
Request a live AQ platform
demonstration.
Thirty minutes on your own studies — documentation, study activity, quality processes and pharmacy, in one governed record.
BOOK A DEMO
Request a Guided AQ Tour
Practical walkthroughs aligned with active research delivery.
We’ll only use your details to arrange your demo and
send relevant AQ updates. No spam.
Used only to arrange your demo. No spam, no third parties.REPLY WITHIN ONE WORKING DAY